Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-6,288
Closed -$240K 899
2024
Q1
$240K Buy
6,288
+319
+5% +$12.1K 0.01% 629
2023
Q4
$222K Buy
5,969
+69
+1% +$2.32K 0.01% 624
2023
Q3
$201K Buy
5,900
+79
+1% +$2.98K 0.02% 612
2023
Q2
$229K Buy
+5,821
New +$210K 0.02% 576
2022
Q2
Sell
-5,336
Closed -$274K 612
2022
Q1
$274K Buy
+5,336
New +$229K 0.03% 455
2021
Q2
Sell
-4,910
Closed -$219K 550
2021
Q1
$219K Buy
+4,910
New +$229K 0.02% 432

Other funds holding PGNY

Caprock Group's PGNY Position: Q2 2024 in Review

Caprock Group sold out of Progyny (PGNY) in Q2 2024, closing a stake of 6,288 shares — an estimated $240K sold.

Caprock Group first reported a position in PGNY in Q1 2021 and held it in 6 quarters. The position peaked at $274K in Q1 2022. 324 funds tracked by Wall St. Rank hold PGNY as of Q2 2024.

  • Caprock Group reported no remaining Progyny position as of Q2 2024 after selling out during the quarter.
  • Caprock Group sold 6,288 Progyny shares in Q2 2024, an estimated $240K.
  • Caprock Group first reported a position in Progyny in Q1 2021 and held it in 6 quarters.
  • Caprock Group's Progyny position peaked at $274K in Q1 2022.
  • 324 funds tracked by Wall St. Rank held Progyny as of Q2 2024.

Based on Caprock Group's 13F filing for Q2 2024, filed 6 Aug 2024.